{"news_desk": "Business", "print_page": "7", "subsection_name": null, "section_name": "Business Day", "byline": {"original": "By KATIE THOMAS", "person": [{"firstname": "Katie", "rank": 1, "lastname": "THOMAS", "organization": "", "role": "reported"}]}, "abstract": "Drug company Kaleo announces it will bring back Auvi-Q, EpiPen alternative taken off market in 2015, in move cautiously welcomed by lawmakers concerned about rising price of EpiPens; it is unclear whether drug will help lower prices of epinephrine-delivery devices given fact that since it previously cost more than EpiPen and generic version is expected to be launched.", "type_of_material": "News", "word_count": "951", "keywords": [{"rank": "1", "value": "Epinephrine (Drug)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Medical Devices", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Allergies", "is_major": "Y", "name": "subject"}, {"rank": "5", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "6", "value": "Kaleo Inc", "is_major": "Y", "name": "organizations"}, {"rank": "7", "value": "Mylan Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "The Auvi-Q, which drew an ardent fan base, was taken off the market in 2015. It is unclear whether its comeback next year will help lower the price of the EpiPen.", "pub_date": "2016-10-26T11:57:04+0000", "document_type": "article", "source": "The New York Times", "snippet": "The Auvi-Q, which drew an ardent fan base, was taken off the market in 2015. It is unclear whether its comeback next year will help lower the price of the EpiPen....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbWide.jpg"}, {"height": 322, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "322", "xlarge": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/10/27/business/27ALLERGY5/27ALLERGY5-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/10/27/business/an-epipen-rival-is-about-to-return-to-the-shelves.html", "slideshow_credits": null, "blog": [], "_id": "58109a1295d0e022439c5497", "headline": {"main": "An EpiPen Rival Is About to Return to the Shelves", "print_headline": "Rival of EpiPen Readies for Return to the Shelves"}}